Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2048 of 5804
-
Blood vessel on a chip could transform bleeding risk tests
Diagnosis Recruiting nowCurrently, the exploration of primary hemostasis (a physiological phenomenon used to stop bleeding) is imperfect because it is based on targeted tests for platelets or von Willebrand factor, without taking into account blood flow and other blood cells (red and white blood cells).…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Blood donation may improve diabetes and fatty liver, study finds
Disease control CompletedThis is a treatment study to determine if reducing the body's iron stores by blood donation will improve diabetes control and other problems associated with diabetes such as fatty liver disease.
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New combo therapy shows promise for stroke patients with paralyzed arms
Symptom relief CompletedChronic stroke patients (\> 6 months) with severe motor impairment of the upper extremity will be enrolled in this single-centre, randomized controlled clinical trial (RCT). All patients will take part in two blocks of high-intense motor training with concurrent neuromuscular sti…
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to control blood sugar in kids with rare condition
Disease control OngoingThis is an open-label, multinational, multicenter, long-term safety and efficacy extension trial in patients with Congenital Hyperinsulinism (CHI) who completed either ZP4207-17103 (NCT04172441) or ZP4207-17109 (NCT03777176) (defined as lead-in trials). The primary objective is …
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Intensive insulin strategy may ease diabetes drug burden
Disease control CompletedDespite advances in diabetes management, many patients with type 2 diabetes in China fail to achieve optimal glycemic control. One of the possible reasons is associated with the delay in therapeutic decision making that lags behind glycemic rise. The investigators design this stu…
Phase: PHASE4 • Sponsor: Yanbing Li • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a simple eye drop boost glaucoma surgery success?
Disease control Recruiting nowThe goal of this study is to determine whether using pilocarpine provides added benefit to the success of combined cataract + Kahook Dual Blade (KDB) surgery.
Phase: PHASE3 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Shocking pain away: tDCS and exercise tested for fibromyalgia
Symptom relief CompletedThis trial aims at understanding the mechanisms of optimized transcranial direct current stimulation (tDCS) (16 tDCS sessions combined with exercise)\] on pain control. Optimized tDCS can lead to stronger engagement of the endogenous pain regulatory system that will ultimately le…
Phase: NA • Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Can beetroot juice boost brain and body function in kidney patients?
Disease control OngoingNitric oxide (NO) is an essential molecule in the body that is decreased in patients with chronic kidney disease (CKD), leading to reductions in vascular, movement ("motor") and cognitive functions. This study will determine if daily oral supplementation (3 months) with a supplem…
Phase: PHASE4 • Sponsor: University of Colorado, Boulder • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New blood thinner may simplify stroke prevention after heart surgery
Disease control CompletedThis prospective, randomized, active-controlled, parallel arm study compares the safety and financial benefits of arterial thromboembolism prophylaxis with Warfarin vs. Rivaroxaban (A novel oral anticoagulant) in patients with new onset atrial fibrillation after sternotomy for ca…
Phase: PHASE3 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New radiation approach aims to reduce dry mouth in throat cancer patients
Symptom relief CompletedThe purpose of this study is to compare the toxicity and therapeutic efficacy of proton or photon combined with carbon ion radiotherapy for newly diagnosed nasopharyngeal carcinoma.Participants will be randomized to 2 arms. Arm 1, participants received photon combined with carbon…
Phase: PHASE2 • Sponsor: Shanghai Proton and Heavy Ion Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New antibody aims to unleash immune system against advanced tumors
Disease control CompletedThis is a phase I, open-label, multiple-dose, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and anti-tumor activity of LDP in subjects with advanced malignant tumors.
Phase: PHASE1 • Sponsor: Dragonboat Biopharmaceutical Company Limited • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Oxygen boost for unborn babies with heart disease shows promise
Knowledge-focused CompletedCongenital heart disease (CHD) is predominantly detected before birth. Using echocardiography and MRI, this study will determine whether acute exposure to maternal hyperoxygenation (MH) leads to measurable increases in fetal cerebral oxygenation from baseline in fetuses with CHD.…
Phase: NA • Sponsor: The Hospital for Sick Children • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New combo therapy shows promise for Tough-to-Treat lymphoma
Disease control CompletedA multicenter trial evaluating the combination of nivolumab and the antagonistic CSF-1R monoclonal antibody cabiralizumab (BMS-986227) in patients with relapsed/refractory peripheral T cell lymphoma
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Rheumatoid arthritis drug baricitinib put to the test against TNF blockers in major safety trial
Disease control CompletedThis post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis.
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Zapping the brain to calm dementia agitation
Knowledge-focused OngoingAgitation and aggression impose a tremendous burden on the individuals living with dementia, their families, caregivers, and healthcare systems. Neuropsychiatric symptoms of dementia (NPS) affect up to 80% of patients with Alzheimer's dementia (AD). The mechanisms of agitation in…
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Custom ventilation during surgery may cut lung risks
Disease control CompletedThe purpose of this international multicenter, patient and outcome-assessor blinded randomized controlled trial is to determine whether the application of an individualized high PEEP strategy, aiming at avoiding an increase in the driving pressure during intraoperative ventilatio…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a bone drug stop smoldering myeloma in its tracks?
Disease control CompletedThis study will assess the safety and tolerability of denosumab in smoldering multiple myeloma subjects as well to see if denosumab can reduce subjects' risk of getting multiple myeloma.
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Weight-Loss drug shows promise for pancreatic cancer patients
Symptom relief CompletedThis phase II trial studies how well telotristat ethyl works in promoting weight stability in patients with pancreatic adenocarcinoma that has come back and spread to other places in the body. Telotristat ethyl may decrease bowel movements which may make patients gain weight. Sta…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Robots take on knee surgery: could precision mean less pain?
Symptom relief Recruiting nowTotal knee replacement surgery is a conventional approach to alleviating the pain and lack of function resulting from arthritis of the knee. While conventional knee replacement surgery is highly successful, incidences of improperly installed replacement parts are not uncommon. To…
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 26, 2026 14:39 UTC
-
Nighttime sedative may cut delirium in elderly heart surgery patients
Symptom relief CompletedDelirium is an acutely occurred and fluctuating cerebral dysfunction characterized with inattention, altered consciousness, cognitive decline and/or abnormal perception. It is common in the elderly after cardiac surgery and is associated with worse outcomes. Causes leading to del…
Phase: NA • Sponsor: Dong-Xin Wang • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC